![Matthew Bartholomae](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew Bartholomae
Keine laufenden Positionen mehr
Aktive Positionen von Matthew Bartholomae
Unternehmen | Position | Beginn | Ende |
---|
Karriereverlauf von Matthew Bartholomae
Ehemalige bekannte Positionen von Matthew Bartholomae
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MINERVA NEUROSCIENCES, INC. | General Counsel | 01.01.2016 | 01.01.2018 |
CARTESIAN THERAPEUTICS, INC. | General Counsel | 01.12.2020 | - |
Unternehmenssekretär | 01.12.2020 | - |
Ausbildung von Matthew Bartholomae
Boston College | Undergraduate Degree |
University of New Hampshire School of Law | Graduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
General Counsel | 3 |
Corporate Secretary | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MINERVA NEUROSCIENCES, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Selecta Biosciences, Inc.
![]() Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
- Börse
- Insiders
- Matthew Bartholomae
- Erfahrung